Engraftable neural progenitor and stem cells for brain tumor therapy
CA 2313169 C · Owner: Snyder, Evan Y. · Inventors: Lynch, William P.; Aboody, Karen; Breakefield, Xandra O.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
One of the impediments to the treatment of some human brain tumors (e.g. gliomas) has been the degree to which they expand migrate widely, and , infiltrate normal tissue. We demonstrate that a clone of multipotent neural progenitor stem cells, when implanted into an experimental glioma will , migrate along with and distribute themselves throughout the tumor in juxtaposition to widely expanding and aggressively advancing tumor cells while continuing to express a foreign reporter gene. Furthermore drawn , somewhat by the degenerative environment created just beyond the infiltrating tumor edge, the neural progenitor cells migrate slightly beyond and surround the invading tumor border. When …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 17, 1999 and granted June 25, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 17, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 17, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.